Latest Retirement News

Navigator Global Investments grew assets under management by 21% to USD33.6 billion in FY26 but reported a 10% drop in adjusted EBITDA and suspended dividends to fund expansion, including a major acquisition closed post-year-end.

Regal Partners surged to a 258% jump in statutory profit and 21% growth in funds under management, declaring a fully franked 12 cent interim dividend.

Endeavour Group’s FY26 results show modest sales growth but a sharp profit decline due to $372 million in significant item expenses, alongside a strategic reset and climate commitments.

nib Group reported a 6.2% revenue increase to $3.8 billion and a 9.1% rise in underlying operating profit to $260.9 million for FY26, despite a 5.9% net profit dip. The company achieved maiden profitability in Health Services and declared a fully franked 21c dividend including a 5c special, supported by ongoing Travel insurance divestments.

Ansell Limited (ASX:ANN) reported a robust FY26 with net profit doubling to US$208.6 million, driven by strong sales growth and operational resilience amid geopolitical challenges. The company also announced a leadership change and reaffirmed its sustainability ambitions.

Chorus reported solid FY26 results with revenue growth driven by fibre expansion and disciplined cost management, while accelerating copper network retirement and launching new digital infrastructure services.

AdAlta Limited (ASX:1AD) has progressed its ‘East to West’ cellular immunotherapy strategy by securing its first CAR-T asset, advancing Australian manufacturing and US FDA regulatory engagement, while raising A$5.3 million in FY2026 and reporting a net loss of $4.68 million.

South Port New Zealand has delivered a record full-year profit in FY26, driven by a strong 11.5% rise in cargo volumes and significant container throughput growth. The company is positioning for future expansion amid leadership changes and cautious FY27 outlook.

Charter Hall Social Infrastructure REIT (ASX:CQE) posted a robust FY26 result with a 13.1% rise in operating earnings per unit, driven by strategic acquisitions and disciplined capital recycling. The portfolio now boasts a $2.3 billion valuation, near-full occupancy, and extended lease terms, underpinning income resilience amid ongoing sector demand.

Prescient Therapeutics cut its net loss by 4.4% to $7 million in FY26 while expanding its PTX-100 Phase 2a trial across three continents and securing key regulatory designations in Europe and the US.

Accent Group posted a statutory loss for FY26 driven by a significant goodwill impairment, while reaffirming its 2030 growth ambitions and urging shareholders to reject Frasers Group's takeover offer.

LGI Limited posted a robust FY26 with a 35.5% rise in net profit, underpinned by a 33% jump in biogas flows and a $56 million capital raise fueling expansion beyond 80MW.